1590. Resistance to Etravirine, Doravine and Rilpivirine in People Living with HIV Experiencing Virologic Failure to a First-line Antiretroviral Regimen Based on a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) in a Latin American Country.

BACKGROUND: To date, etravirine (ETR) is the only NNRTI indicated in people living with HIV (PLHIV) after virologic failure (VF) to first-generation NNRTIs. Data about susceptibility to ETR, doravirine (DOR) and rilpivirine (RPV) after VF in PLHIV from Latin American countries are scarce. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mingrone, Verónica, Loiza, Eliana, Porteiro, Norma, Ballivian, Jamile, Córdova, Ezequiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679141/
http://dx.doi.org/10.1093/ofid/ofad500.1425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679141/
http://dx.doi.org/10.1093/ofid/ofad500.1425

Ejemplares similares